The Interplay Between Depression, Probiotics, Diet, Immunometabolic Health, the Gut, and the Liver—A Secondary Analysis of the Pro-Demet Randomized Clinical Trial
Nutrients · 2024
DOI: 10.3390/nu16234024 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Oliwia Gawlik-Kotelnicka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Affective and Psychotic Disorders, Medical University of Lodz, 92-216 Lodz, Poland. Hauptthemen laut MEDLINE: Probiotics, Depression, Liver. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Lodz.
Themen: Depression
Abstract (Originalsprache)
(1)
Background
Depression, metabolic alternations, and liver diseases are highly comorbid. Studies have shown that probiotics might be helpful in the treatment of the above-mentioned states. The aim of this secondary analysis was to search for possible predictors of probiotics’ efficacy on liver-related outcome measures. (2)
Methods
Data from 92 subjects from a randomized clinical trial on the effect of probiotics on depression were analyzed. The shift in liver steatosis and fibrosis indices was assessed in the context of baseline immunometabolic, psychometric, dietary, and intestinal permeability factors. Correlation analysis and linear regression models were used. (3)
Results
A total of 30% of the variance of the improvement in the score of the aspartate transferase to platelet ratio index was explained by probiotic use, higher pre-intervention triglycerides, cholesterol, C-reactive protein levels, increased cereal intake, and a lower consumption of sweets. Then, the model of the change in alanine transferase indicated that probiotics were efficient when used by subjects with higher basal levels of intestinal permeability markers. (4)
Conclusions
Probiotics being used along with a healthy diet may provide additional benefits, such as decreased cardiovascular risk, for patients with measures consistent with the immunometabolic form of depression. Probiotic augmentation may be useful for liver protection among subjects with a suspected “leaky gut” syndrome. ClinicalTrials.gov: NCT04756544.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Affective and Psychotic Disorders, Medical University of Lodz, 92-216 Lodz, Poland.
- University Clinical Hospital No. 2, Medical University of Lodz, 90-549 Lodz, Poland.
- Department of Biomedicine and Genetics, Medical University of Lodz, 92-213 Lodz, Poland.
- Department of Biostatistics and Translational Medicine, Medical University of Lodz, 92-215 Lodz, Poland.
ORCID-Profile: Oliwia Gawlik-Kotelnicka, Jakub Rogalski, Karolina H Czarnecka-Chrebelska, Paulina Jakubowska, Dominik Strzelecki
Förderung
- Medical University of Lodz
Zitieren
APA
Gawlik-Kotelnicka, O., Rogalski, J., Czarnecka-Chrebelska, K. H., Burzyński, J., Jakubowska, P., Skowrońska, A., & Strzelecki, D. (2024). The Interplay Between Depression, Probiotics, Diet, Immunometabolic Health, the Gut, and the Liver—A Secondary Analysis of the Pro-Demet Randomized Clinical Trial. Nutrients. https://doi.org/10.3390/nu16234024
Vancouver
Gawlik-Kotelnicka O, Rogalski J, Czarnecka-Chrebelska KH, Burzyński J, Jakubowska P, Skowrońska A, et al. The Interplay Between Depression, Probiotics, Diet, Immunometabolic Health, the Gut, and the Liver—A Secondary Analysis of the Pro-Demet Randomized Clinical Trial. Nutrients. 2024. doi:10.3390/nu16234024
BibTeX
@article{GawlikKotelnicka2024,
author = {Gawlik-Kotelnicka, Oliwia and Rogalski, Jakub and Czarnecka-Chrebelska, Karolina H and Burzyński, Jacek and Jakubowska, Paulina and Skowrońska, Anna and Strzelecki, Dominik},
title = {The Interplay Between Depression, Probiotics, Diet, Immunometabolic Health, the Gut, and the Liver—A Secondary Analysis of the Pro-Demet Randomized Clinical Trial},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16234024}
}
EUVIMED